• Research & Development

  Improving Heart and Lung Function with Adempas Therapy

  Posted by Pulmonary Hypertension News Moderator on August 6, 2018 at 6:00 pm

  Adempas therapy significantly improves lung and heart function in patients with chronic thromboembolic pulmonary hypertension (CTEPH) previously treated off-label with sildenafil, according to a Polish study.

  
  Click here to find out more about the study, which looked at what happened when patients stopped taking Sildenafil and started taking Adempas.

  What are your thoughts on this news?

  replied 7 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply